Inventor · disambiguated record
Shuwen He
Also filed as: HE SHUWEN
34 granted patents·14 pending applications·62 citations·filing 2004–2025
95Inventor score
Files withMERCK SHARP & DOHME18KALLYOPE INC16MCCOMAS CASEY C3MERCK SHARP & DOHME LLC3DOBBELAAR PETER H2
Top patents by PatentIndex Score
48 records- 0196US11512065B2GPR119 agonistsKALLYOPE INC·Filed 2022·Granted Nov 29, 2022·7 cites·20 claims
- 0296US11279702B2AMPK activatorsKALLYOPE INC·Filed 2021·Granted Mar 22, 2022·4 cites·19 claims
- 0391US9364482B2Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2014·Granted Jun 14, 2016·8 cites·15 claims
- 0490US9243002B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis CMERCK SHARP & DOHME·Filed 2014·Granted Jan 26, 2016·8 cites·17 claims
- 0588US9265773B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Feb 23, 2016·8 cites·15 claims
- 0684US11851429B2AMPK activatorsKALLYOPE INC·Filed 2022·Granted Dec 26, 2023·1 cites·20 claims
- 0782US12091405B2Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Sep 17, 2024·2 cites·13 claims
- 0882US9242998B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis CHE SHUWEN·Filed 2014·Granted Jan 26, 2016·8 cites·17 claims
- 0981US12152019B2Arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Nov 26, 2024·2 cites·20 claims
- 1080US9573939B2Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Feb 21, 2017·6 cites·6 claims
- 1173US12281114B2NK3 modulators and uses thereofKALLYOPE INC·Filed 2024·Granted Apr 22, 2025·0 cites·20 claims
- 1273US2024101558A1Ampk activatorsKALLYOPE INC·Filed 2023·Application pending·0 cites
- 1372US12264171B2GPR40 agonistsKALLYOPE INC·Filed 2022·Granted Apr 1, 2025·0 cites·6 claims
- 1470US7652024B2Acylated spiropiperidine derivatives as melanocortin-4 receptor modulatorsMERCK SHARP & DOHME·Filed 2006·Granted Jan 26, 2010·2 cites·19 claims
- 1570US2022340599A1Ampk activatorsKALLYOPE INC·Filed 2022·Application pending·0 cites
- 1669US9868738B2Diazine-fused amidines as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2015·Granted Jan 16, 2018·1 cites·13 claims
- 1768US2025276989A1Gpr40 agonistsKALLYOPE INC·Filed 2025·Application pending·0 cites
- 1867US9732088B2C2-carbocyclic iminothiazine dioxides as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2015·Granted Aug 15, 2017·1 cites·9 claims
- 1967US9549917B2Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Jan 24, 2017·1 cites·14 claims
- 2066US2023050965A1Sstr5 antagonistsKALLYOPE INC·Filed 2020·Application pending·0 cites
- 2166US2023041621A1Sstr5 antagonistsKALLYOPE INC·Filed 2020·Application pending·0 cites
- 2266US2023061736A1Gpr119 agonistsKALLYOPE INC·Filed 2022·Application pending·0 cites
- 2365US11407768B2AMPK activatorsKALLYOPE INC·Filed 2021·Granted Aug 9, 2022·0 cites·21 claims
- 2464US7329673B2Acylated spiropiperidine derivatives as melanocortin-4 receptor agonistsMERCK & CO INC·Filed 2004·Granted Feb 12, 2008·2 cites·22 claims
- 2561US8754099B2Oxadiazole beta carboline derivatives as antidiabetic compoundsGUO LIANGQIN·Filed 2011·Granted Jun 17, 2014·1 cites·17 claims
- 2661US2023113609A1Sstr5 antagonistsKALLYOPE INC·Filed 2020·Application pending·0 cites
- 2758US11267786B2[3.3.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Mar 8, 2022·0 cites·18 claims
- 2856US2025263410A1Nk3 modulators and uses thereofKALLYOPE INC·Filed 2025·Application pending·0 cites
- 2954US2023151037A1Gpr40 agonistsKALLYOPE INC·Filed 2021·Application pending·0 cites
- 3052US11352320B2Substituted [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Jun 7, 2022·0 cites·14 claims
- 3152US2022226298A1Gpr40 agonistsKALLYOPE INC·Filed 2020·Application pending·0 cites
- 3251US11478461B2[1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Oct 25, 2022·0 cites·19 claims
- 3351US9549921B2Heterocyclic compounds and methods of use thereof for the treatment of hepatitis CHE SHUWEN·Filed 2014·Granted Jan 24, 2017·0 cites·17 claims
- 3448US12264134B2Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Apr 1, 2025·0 cites·21 claims
- 3548US2016130259A1Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 3644US11034661B2Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Jun 15, 2021·0 cites·19 claims
- 3744US10927086B2Substituted sulfoximine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Feb 23, 2021·0 cites·20 claims
- 3844US9493461B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis CMERCK SHARP & DOHME·Filed 2014·Granted Nov 15, 2016·0 cites·18 claims
- 3942US10988487B2Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Apr 27, 2021·0 cites·20 claims
- 4042US10238743B2C5-C6-fused tricyclic iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2015·Granted Mar 26, 2019·0 cites·11 claims
- 4141US10968232B2Antidiabetic spirochroman compoundsMERCK SHARP & DOHME·Filed 2017·Granted Apr 6, 2021·0 cites·19 claims
- 4241US2010184758A1Beta carboline derivatives as antidiabetic compoundsDOBBELAAR PETER H·Filed 2008·Application pending·0 cites
- 4340US11072602B2Antidiabetic heterocyclic compoundsMERCK SHARP & DOHME·Filed 2017·Granted Jul 27, 2021·0 cites·15 claims
- 4439US10538497B2Compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Jan 21, 2020·0 cites·19 claims
- 4537US10071998B2Iminothiadiazine dioxides bearing an amine-linked substituent as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2016·Granted Sep 11, 2018·0 cites·10 claims
- 4637US8183275B2Substituted imidazoles as bombesin receptor subtype-3 modulatorsDOBBELAAR PETER H·Filed 2007·Granted May 22, 2012·0 cites·15 claims
- 4735US2014088124A1Imidazole derivativesDEVITA ROBERT J·Filed 2012·Application pending·0 cites
- 4834US2010184799A1Oxadiazole beta carboline derivatives as antidiabetic compoundsDU WU·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shuwen He files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →